Next Arc Research

Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.
← Back to Free Archive

Free Tier

Next Arc Research Company Analysis
102 of 102
Total Stocks
Month
Update Cadence
Risk Level (select to filter)
Opportunity Level (select to filter)
Segments (select to filter)
Risk-Weighted Opportunity Quartiles (select to filter)
Showing 0 of 0 stocks
Color by Risk-Weighted Opportunity: Q1 (Low) Q2 Q3 Q4 (High)
# Symbol Segments Name Multiple Alignment Thesis
1 NNOX ai cloud healthcare medical devices software NANO-X IMAGING LTD. 7.0x 0.40 Nanox is a high-variance option on turning a cleared low-cost imaging device into a bundled imaging utility; if it clears financing, activation, and service-attach gates, revenue can compound from a tiny base and the stock can rerate from distressed device optionality toward recurring workflow value.
2 HURA biotech healthcare TuHURA Biosciences, Inc. 5.4x 0.25 TuHURA is a survival-to-scale biotech: if the April 2026 facility carries it through convincing IFx-2.0 Phase 3 proof, the stock can rerate from distressed optionality to a niche oncology commercial and partnering story, with TBS-2025 and DOR programs adding upside without requiring full self-funding.
3 AISP ai defense enterprise hardware software Airship AI Holdings, Inc. 5.1x 0.45 Airship AI can compound from a tiny, lumpy project vendor into a trusted edge-to-evidence workflow company if it converts federal pipeline into repeat deployments, lifts mix toward branded software and support, and monetizes verification-heavy workflows that get more valuable as raw AI detection gets cheaper.
4 DNA ai automation biotech healthcare robotics Ginkgo Bioworks Holdings, Inc. 5.1x 0.40 Ginkgo is a distressed but real option on manual lab work shifting into autonomous, AI-linked biology infrastructure; if it proves repeat utilization before liquidity tightens, modest share gains in a fast-growing automation market can lift revenue several-fold and rerate the stock out of project-shop pricing.
5 RR ai automation enterprise hardware robotics Richtech Robotics Inc. 4.9x 0.40 Richtech is a cash-rich option on service robotics adoption: if it turns demos and channel reach into dense multi-site RaaS and workflow-embedded contracts, revenue can scale non-linearly from a tiny base; if not, it remains a low-volume robot vendor with weak pricing power.
6 RXRX ai automation biotech healthcare software Recursion Pharmaceuticals, Inc. 4.5x 0.55 Recursion can rerate from a cash-backed proof story into a hybrid product-and-platform biotech if REC-4881 secures a workable registrational path and at least one more internal asset validates repeatable platform translation; that quality shift in revenue is the core 2031 value driver.
7 SERV ai automation healthcare robotics transportation Serve Robotics Inc. 3.9x 0.56 Serve is a leveraged bet that autonomous delivery and hospital logistics shift from robot-count stories to dense recurring utilization; if it converts its installed fleet, hospital workflow footprint, and software layer into durable revenue per operating hour, market cap can still compound meaningfully from here.
8 ACHR aerospace automation defense evtol transportation Archer Aviation Inc. 3.9x 0.55 Archer can compound from near-zero revenue into a meaningful regulated aviation platform if it converts 2026 certification and pilot operations into repeatable city launches, then captures recurring economics through operating software, launch bundles, defense variants, and scarce node access rather than relying only on aircraft sales.
9 SDGR ai biotech cloud healthcare software Schrödinger, Inc. 3.7x 0.60 The five-year upside is a workflow-quality upgrade, not a heroic biotech bet: if hosted delivery, LiveDesign embedment, and Bunsen turn Schrödinger from a respected modeling toolkit into a governed discovery operating layer, revenue can more than double and the stock can rerate toward specialized scientific software with biotech option value attached.
10 PRME biotech healthcare Prime Medicine, Inc. 3.6x 0.37 Prime Medicine is a financing-constrained but differentiated editing platform; if PM359 reaches a workable regulatory path and PM577 plus PM647 validate a reusable liver franchise, the stock can rerate from cash-box optionality to a multi-asset precision-genetics company, though dilution will absorb part of the upside.
11 MSTR ai crypto enterprise finance software Strategy Inc 3.5x 0.40 Over the next five years, Strategy can still compound equity at a low-20s rate if it keeps growing bitcoin holdings faster than claim dilution and turns its software into a governed trust layer for AI and treasury workflows; the upside is real, but the binding gate is capital-markets access, not software demand.
12 BEAM biotech healthcare Beam Therapeutics Inc. 3.5x 0.40 Beam can rerate from cash-plus-platform optionality to a two-franchise editing company if risto-cel reaches market and BEAM-302 stays on a pivotal path; additive upside comes from owning treatment workflows, trusted manufacturing quality, and selective platform deals that turn scientific learning into durable revenue.
13 QUBT ai cybersecurity hardware quantum semiconductors Quantum Computing Inc. 3.4x 0.38 QCi can grow from an acquisition-boosted micro-scale story into a niche U.S. photonics infrastructure and quantum-security supplier if it converts backlog, foundry know-how, and balance-sheet strength into recurring higher-utilization revenue before the market stops funding option value.
14 INOD ai cloud enterprise software Innodata Inc. 3.1x 0.44 Innodata is riding a real AI deployment bottleneck, and the 5-year win is not becoming pure software but turning fast-growing project work into recurring assurance, observability, and governed workflow revenue before hyperscalers or top customers internalize too much of the stack.
15 QBTS cloud enterprise hardware quantum software D-Wave Quantum Inc. 3.1x 0.52 D-Wave can evolve from a lumpy quantum vendor into optimization infrastructure by converting backlog, scarce hardware access, and the Quantum Circuits roadmap into recurring workflow contracts; the opportunity is real, but the stock already prices in enough future success that execution matters more than storytelling.
16 AI ai cloud defense enterprise software C3.ai, Inc. 3.0x 0.40 C3 AI is a repair-and-rerate enterprise AI stock: if restructuring cuts burn, partner/federal channels turn proofs into repeatable production deployments, and pricing shifts toward trusted workflow control rather than generic AI access, a depressed starting EV can still compound into a credible 2x equity outcome by 2031.
17 PDYN aerospace ai defense robotics software Palladyne AI Corp. 3.0x 0.45 Palladyne can grow from a tiny base into a credible defense-autonomy supplier if recent acquisitions, backlog, and field validation convert into repeat programs, then higher-value assurance, partner distribution, and support revenue lift mix; the upside is real because the starting base is small, but mixed hardware/services and financing risk should cap the terminal multiple below elite software names.
18 CRSP biotech healthcare CRISPR Therapeutics AG 2.9x 0.40 CRISPR Therapeutics can move from a one-product proof story to a two-engine editing company if CASGEVY keeps scaling and one owned franchise, most likely liver editing or zugo-cel, crosses into clear commercial relevance by 2031.
19 POET ai communications hardware networking semiconductors POET Technologies Inc. 2.9x 0.45 POET sits in a real AI-era bottleneck because faster clusters need denser, lower-power optical links, but shareholder returns now depend less on technical relevance and more on proving Malaysia volume readiness, converting Lumilens and partner programs into repeat shipments, and capturing some IP-like mix before larger optics vendors absorb the economics.
20 ESTC ai cloud cybersecurity enterprise software Elastic N.V. 2.8x 0.58 Elastic is a discounted AI-era context layer: if it turns rising search, security, observability, and regulated-agent workloads into durable paid usage with better cloud economics, revenue can roughly double by 2031 and the stock can compound above market norms without needing a premium-software multiple.
21 RDVT ai cloud enterprise finance software Red Violet, Inc. 2.8x 0.60 RDVT is a profitable identity-intelligence utility that should benefit as AI agents and digital workflows create more verification, fraud, and due-diligence events; if management keeps embedding CORE deeper into contracted workflows and adds higher-value monitoring and trust products, revenue can roughly triple by 2031 without needing heroic market-share gains.
22 AUR ai automation robotics software transportation Aurora Innovation, Inc. 2.8x 0.67 Aurora can turn early driverless-trucking proof into a valuable freight control point if it converts lane validation, OEM integration, and safety trust into dense contracted corridor capacity before dilution and partner bargaining absorb the economics.
23 IREN ai cloud crypto energy hardware IREN Limited 2.8x 0.67 IREN can compound by turning scarce power-connected campuses into contracted AI capacity faster than it dilutes shareholders; if it evolves into a repeatable allocator and operator of compute infrastructure, not just a miner-turned-landlord, the upside remains nonlinear even after the rerating.
24 SMR energy hardware nuclear NuScale Power Corporation 2.8x 0.66 NuScale is a leveraged option on AI-era firm-power scarcity: if its NRC-approved design converts into one bankable U.S. project plus continued Romania progress and attached lifecycle services, revenue can inflect from trivial engineering fees to meaningful module and services revenue by 2031, but the stock still needs commercial proof rather than more technical validation.
25 ZS ai cloud cybersecurity enterprise software Zscaler, Inc. 2.8x 0.65 Zscaler already owns an inline enterprise trust gate that should become more valuable as AI expands traffic, machine identities, data egress, and sovereignty needs; if it converts that position from mostly seat-led subscriptions into broader usage, agent, and regulated-trust monetization, revenue can more than double by 2031 without needing a return to its old peak multiple.
26 TEM ai biotech enterprise healthcare software Tempus AI, Inc. 2.7x 0.60 Tempus can compound at a bull-case rate if it keeps turning each diagnostic interaction into governed data, workflow, and life-sciences revenue, while the May 2026 refinancing gives it more time for MRD reimbursement and assay approvals to mature. The upside is mostly mix shift and scale, not a heroic rerating.
27 S ai cloud cybersecurity enterprise software SentinelOne, Inc. 2.7x 0.60 SentinelOne can roughly 2.5x enterprise value by 2031 if it keeps turning endpoint footholds into broader cloud, identity, data, and AI-security spend while becoming a trusted automation and evidence layer rather than just another detection vendor.
28 BFLY ai hardware healthcare medical devices software Butterfly Network, Inc. 2.7x 0.61 Butterfly has a credible path from niche handheld-ultrasound vendor to higher-quality imaging platform if iQ3 adoption, enterprise workflow, and Embedded licensing become repeatable enough to turn a device story into a recurring mix-shift story.
29 FLNC ai automation energy enterprise software Fluence Energy, Inc. 2.7x 0.60 Fluence can compound by turning a record storage backlog, early hyperscaler access, and policy-aware sourcing into a larger installed base that carries more software, services, and financing support; if it shifts from selling battery projects to owning operating outcomes, value can scale faster than hardware margins alone imply.
30 JOBY aerospace automation defense evtol transportation Joby Aviation, Inc. 2.6x 0.60 If Joby clears certification and launches dense premium corridors, its regulated aircraft-plus-distribution stack can compound into a scarce mobility network and recurring fleet-services business; the upside is real, but the stock already prices in substantial success so execution must convert approvals into utilization.
31 PATH ai automation cloud enterprise software UiPath, Inc. 2.6x 0.46 UiPath is no longer just an RPA vendor; the 5-year upside comes from turning its installed base into a governed orchestration layer for agents, robots, and people. If it monetizes trust, exception handling, and regulated deployment better than seat counts shrink, revenue can roughly double and the stock can re-rate modestly from a reset base.
32 RCAT aerospace automation defense hardware robotics Red Cat Holdings, Inc. 2.6x 0.56 Red Cat can grow into a trusted Western small-systems prime if it converts compliance-led demand into repeat deliveries, better manufacturing economics, and stickier readiness revenue before larger incumbents compress hardware margins.
33 NBIS ai cloud enterprise hardware software Nebius Group N.V. 2.6x 0.70 Nebius has real non-linear upside because it controls scarce AI power, GPU capacity and a growing inference stack, but the stock will only compound if management turns contracted capacity into highly utilized revenue fast enough and proves Token Factory can lift it above commodity compute pricing.
34 OUST ai automation hardware robotics software Ouster, Inc. 2.6x 0.50 Ouster can still create a solid 5-year winner if Rev8 plus Stereolabs turns it from a sensor vendor into a workflow-embedded perception stack for robots, industrial sites, and intersections; the upside is real, but it now requires repeated proof of software attach and margin durability because the stock has already rerated hard.
35 RLAY ai biotech healthcare Relay Therapeutics, Inc. 2.6x 0.35 If zovegalisib converts early promise into durable registrational proof in second-line breast cancer and opens a real vascular-anomalies pillar, Relay can rerate from a single-asset clinical story into an emerging precision-medicine franchise; the upside is real, but it still depends on proof more than platform narrative.
36 SOUN ai automation automotive enterprise software SoundHound AI, Inc. 2.6x 0.46 Over five years, the stock can still compound if SoundHound turns OASYS, Amelia, and the planned LivePerson footprint into a deeper omnichannel workflow layer with transaction control, partner distribution, and better pricing mix; the opportunity is real, but upside depends on capturing value above raw voice usage before larger platforms compress the layer.
37 IONQ cloud defense hardware quantum space IonQ, Inc. 2.5x 0.60 IonQ can still compound meaningfully if it turns trapped-ion leadership, broader quantum-platform demand, and SkyWater-enabled manufacturing control into repeatable system sales and contracted cloud revenue; from here, upside comes mostly from delivered revenue scaling faster than valuation compresses.
38 LMND ai finance software Lemonade, Inc. 2.5x 0.47 Lemonade can become a meaningfully larger self-funding personal-lines insurer by 2031 if 2026 proves that its AI-native underwriting and claims stack can sustain better loss costs, support faster car and pet expansion, and lift household wallet share without another capital reset.
39 AMBA ai automotive hardware robotics semiconductors Ambarella, Inc. 2.5x 0.60 Ambarella is a real edge-AI silicon supplier, not a concept stock; if CV7, automotive, robotics, and higher-value software or custom programs convert from design wins into production, revenue can roughly triple by 2031 and support a 2x-plus equity outcome even with a lower terminal revenue multiple.
40 COIN crypto enterprise finance software Coinbase Global, Inc. 2.5x 0.62 Coinbase can grow from a cyclical crypto broker into a regulated onchain financial utility: if USDC, custody, derivatives, developer rails, and agent-ready payments outgrow spot-fee cyclicality, the business can compound at a solid double-digit rate and rerate modestly by 2031.
41 KTOS aerospace defense hardware software space Kratos Defense & Security Solutions, Inc. 2.4x 0.60 Kratos is a leveraged bet on affordable AI-era defense mass: if drones, propulsion, hypersonics, and space-ground awards convert into repeat production, revenue can reach 4200 by 2031 and equity value can plausibly more than double without needing software-style margins.
42 BBAI ai automation defense enterprise software BigBear.ai Holdings, Inc. 2.3x 0.40 BigBear.ai is a high-beta productization story: if Ask Sage and adjacent mission tools become embedded, trusted workflow software for regulated users, revenue can outgrow today’s contractor profile; if not, the stock remains an expensive, lumpy federal services name.
43 ALAB ai hardware networking semiconductors software Astera Labs, Inc. 2.3x 0.62 Astera can still compound by raising content per AI rack from retimers into switches, modules, custom links and eventually trusted operations software, but shareholder upside now depends on broad Scorpio qualification and customer diversification because the stock already prices in rare execution.
44 OKLO ai defense energy healthcare nuclear Oklo Inc. 2.3x 0.63 Oklo is a scarce option on AI-era clean firm power and fuel security: if recent DOE/NRC progress, early isotope sales, and Meta-backed Ohio development convert into one operating Idaho asset plus an initial campus rollout, the stock can still rerate as an early nuclear-capacity platform, though today’s valuation already assumes meaningful success.
45 SNOW ai cloud enterprise software Snowflake Inc. 2.3x 0.65 Snowflake can compound above software-market norms if it becomes the governed runtime for enterprise AI and verified agent workflows, not just a data warehouse; usage pricing scales with workloads, but hyperscaler bundling and open data stacks should cap upside to premium compounding rather than extreme rerating.
46 APLD ai cloud crypto energy Applied Digital Corporation 2.3x 0.74 Applied Digital can grow into a materially larger AI infrastructure owner if it converts scarce powered sites and 900 MW of contracted campuses into recurring lease revenue faster than financing costs, utility gates, and dilution erode common-equity value; the upside is real because power is scarce, but the stock now needs execution more than another narrative rerating.
47 APP advertising ai media software AppLovin Corporation 2.3x 0.66 AppLovin is a rare ad-tech company where AI directly improves the core product and the cash engine is already proven; if Axon broadens from gaming into consumer, commerce, and connected TV without breaking publisher economics, revenue can still compound rapidly enough to overcome multiple compression from an already rich starting valuation.
48 SMCI ai cloud enterprise hardware networking Super Micro Computer, Inc. 2.3x 0.46 Supermicro can still compound if it turns AI demand into a cleaner, more trusted systems business: fast rack-scale delivery, liquid cooling, and broader deployment scope should keep revenue growing, while even modest mix improvement and balance-sheet repair can drive a rerating; the catch is that equity upside depends more on cash conversion and compliance credibility than on raw end-demand.
49 FIVN ai cloud communications enterprise software Five9, Inc. 2.2x 0.40 Five9 is a real workflow asset in a growing AI contact-center market, and the stock can still compound if management turns AI from a seat-deflation threat into usage-, governance-, and partner-led revenue; the upside is a rerating from a depressed base, not a heroic land grab.
50 RIOT cloud crypto energy hardware Riot Platforms, Inc. 2.2x 0.60 Riot’s upside is a physical bottleneck story: if it converts even a modest share of its approved Texas power capacity into repeatable AI campus leases while using mining and engineering cash flows as funding tools, revenue quality and valuation can shift materially higher by 2031.
51 CRBS ai cloud enterprise hardware semiconductors Cerebras Systems Inc. 2.2x 0.80 Cerebras has a credible path from bespoke AI hardware vendor to multibillion-dollar inference utility because it controls differentiated wafer-scale compute and has real OpenAI and AWS distribution vectors; the business could scale non-linearly, but the stock starts from a valuation that already prices in years of success.
52 DDOG ai cloud cybersecurity enterprise software Datadog, Inc. 2.2x 0.60 Datadog is a strong AI-era compounder because AI makes software estates more complex, failure-prone, and security-sensitive, expanding demand for unified telemetry and workflow control; the realistic upside is deeper spend per enterprise customer and movement into trusted automation, not unlimited multiple expansion.
53 CRWV ai cloud enterprise software CoreWeave, Inc. 2.2x 0.82 CoreWeave can still be a strong 5-year winner if it keeps turning signed AI demand, contracted power, and structured finance into live high-utilization clusters, then adds more inference and workflow revenue before raw GPU scarcity normalizes.
54 ASTS communications defense hardware networking space AST SpaceMobile, Inc. 2.1x 0.72 AST owns a scarce mix of spectrum access, carrier distribution, and vertically integrated satellite manufacturing; if it clears launch and approval gates and shifts monetization from raw capacity to embedded, reserve-style carrier economics, revenue can inflect sharply by 2031, though today’s valuation already assumes meaningful success.
55 TWST ai automation biotech healthcare Twist Bioscience Corporation 2.1x 0.55 Twist is a biology picks-and-shovels platform whose upside comes from turning AI-driven sequence demand into harder-to-copy manufacturing throughput, broader workflow mix, and better ordering control; if it proves Complex Genes, sustains margin gains, and reduces cash burn, the equity can compound meaningfully without needing a euphoric rerating.
56 CRNC ai automotive enterprise software Cerence Inc. 2.1x 0.45 Cerence is a proof-and-rerating small cap: if xUI moves from launches into repeatable production revenue, connected attach keeps compounding, and debt keeps falling, its embedded OEM footprint can monetize more like durable auto AI software than a noisy legacy voice supplier.
57 PANW ai cloud cybersecurity enterprise software Palo Alto Networks, Inc. 2.1x 0.72 PANW should remain an AI-era security compounder: as machine identities, agent workflows, and attack volume grow, it can capture more wallet share by owning policy, logging, identity, and response control points, pushing revenue into the low-$20B range by 2031 without requiring heroic TAM assumptions.
58 CRDO ai cloud hardware networking semiconductors Credo Technology Group Holding Ltd 2.1x 0.60 Credo already sits in a real AI bottleneck - reliable, low-power links inside hyperscale clusters - and the five-year upside is turning its AEC beachhead into a broader optical DSP, transceiver and silicon-photonics stack while preserving enough qualification-driven pricing power to outrun multiple compression.
59 MRVL ai cloud hardware networking semiconductors Marvell Technology, Inc. 2.1x 0.68 Marvell is a real AI infrastructure beneficiary: if custom ASIC, optical and scale-up connectivity content expands from isolated sockets into multi-control-point rack positions, revenue can roughly triple by 2031; the stock can still deliver low-end 2x upside even with multiple compression.
60 NTRA ai biotech cloud healthcare Natera, Inc. 2.1x 0.60 Natera can compound into a larger precision-diagnostics control point as Signatera expands through evidence and coverage, while women’s health and organ health fund scale; the stock works if oncology keeps premium economics long enough for revenue to outrun multiple compression.
61 RGTI cloud hardware quantum semiconductors Rigetti Computing, Inc. 2.1x 0.40 Rigetti can grow non-linearly from a tiny revenue base if its full-stack superconducting platform turns 108-qubit availability into recurring sovereign systems, reserved-capacity contracts, and higher-trust workflow revenue; but from a multi-billion-dollar starting valuation, shareholder upside now depends on visible commercial proof, not just better lab metrics.
62 RMBS ai cybersecurity hardware networking semiconductors Rambus Inc. 2.1x 0.60 Rambus is an asset-light way to own rising AI memory, interconnect, and silicon-trust complexity: if DDR5/MRDIMM and SOCAMM ramps, HBM and PCIe IP, and higher-value security attach convert from roadmap into volume, revenue can more than triple by 2031, though most equity upside must come from execution rather than further multiple expansion.
63 CLS ai cloud communications hardware networking Celestica Inc. 2.0x 0.60 Over the next five years Celestica can keep moving from generic contract manufacturing toward an AI infrastructure enabler by turning networking, rack integration and U.S. capacity into stickier, higher-value programs; if it converts that mix shift without losing bargaining power to a few large customers, revenue can nearly double and equity value can roughly double without needing a software-style rerating.
64 LSCC ai communications cybersecurity hardware semiconductors Lattice Semiconductor Corporation 2.0x 0.60 Lattice can outgrow the mid-cap semiconductor pack by owning the low-power control, security, and manageability layer around AI racks and intelligent edge systems; if AMI closes and recurring firmware and support revenue deepen value capture, revenue can scale meaningfully even though the stock already embeds high expectations.
65 AMZN advertising ai cloud enterprise transportation Amazon.com, Inc. 2.0x 0.85 Amazon can still compound from an enormous base because AI shifts value toward scarce compute, trusted execution, and transaction rails—three areas it already controls through AWS, enterprise security/compliance tooling, and Prime fulfillment—so the core debate is return on capex, not end-demand.
66 FN automation communications hardware networking Fabrinet 2.0x 0.60 Fabrinet is a scarce, qualified manufacturing choke point for AI-era optics; if new capacity, merchant transceiver ramps, and better supply assurance convert today’s constrained demand into shipments, revenue can more than double by 2031, though the stock outcome still depends on preserving scarcity economics rather than sliding back to ordinary EMS pricing.
67 SYM ai automation enterprise robotics software Symbotic Inc. 2.0x 0.68 Symbotic is a physically embedded warehouse-orchestration winner: if it converts its backlog into a broader installed base and layers trusted recurring workflows on top, revenue can reach 10000 by 2031 and equity can still roughly double despite multiple compression.
68 AMD ai cloud enterprise hardware semiconductors Advanced Micro Devices, Inc. 2.0x 0.76 AMD is one of the few scaled alternatives in AI compute and can roughly triple revenue by 2031 through EPYC share gains plus Instinct and Helios ramps, but with the equity already discounting substantial success, likely shareholder returns are solid rather than explosive.
69 AMPX aerospace defense energy hardware transportation Amprius Technologies, Inc. 2.0x 0.58 Amprius has a real performance edge in weight-sensitive batteries and a credible capital-light path to scale; if it converts NDAA-aligned supply, partner manufacturing and module-level upsell into repeat defense, drone and mobility programs, revenue can grow non-linearly even though the stock still needs heavy multiple compression to work.
70 HUT ai cloud crypto energy hardware Hut 8 Corp. 1.9x 0.60 Hut 8 can still create strong equity value if it turns scarce power access into delivered, long-duration AI infrastructure revenue faster than it issues equity; the real non-linear upside is making project financing and campus commercialization repeatable across its controlled megawatts, with Bitcoin serving as flexible load and treasury optionality rather than the core thesis.
71 COHR automation communications hardware networking semiconductors Coherent Corp. 1.9x 0.74 Coherent owns scarce photonics process depth and manufacturing capacity at a real AI-networking bottleneck; if it converts the InP ramp, 1.6T and 3.2T optics, optical switching, and early next-architecture content into multi-year supply relationships, revenue can roughly double by 2031 even without a heroic rerating.
72 AVGO ai cloud networking semiconductors software Broadcom Inc. 1.9x 0.80 Broadcom is one of the few mega-caps that can still compound non-linearly because it sells scarce AI cluster content, deep co-design know-how and a sticky VMware control layer; if it converts those positions into longer-duration economics, revenue and value can outgrow its already huge base.
73 SNPS ai cloud enterprise semiconductors software Synopsys, Inc. 1.9x 0.79 Synopsys should keep compounding because AI increases the amount of chip and system work that must pass through trusted engineering approval flows; the upside is broader wallet capture across EDA, IP, verification and simulation, while the key debate is whether that value is monetized as workflow outcomes rather than just more tool access.
74 TSLA ai automation automotive energy transportation Tesla, Inc. 1.9x 0.65 Tesla can still roughly double by 2031 if it turns its vehicle-and-battery base into a broader autonomy, charging and energy-services stack; the upside does not require a pure robotaxi moonshot, but it does require mix shift, regulatory progress and better monetization of Tesla-controlled rails.
75 CDNS ai automation hardware semiconductors software Cadence Design Systems, Inc. 1.9x 0.78 Cadence should keep compounding because AI makes chip, package and system design harder, pushing more spend into the validated EDA, IP, verification and simulation workflows it already controls; the upside comes from turning AI into workflow ownership and broader system-analysis share, while the main limits are valuation and export-control friction.
76 NET ai cloud cybersecurity networking software Cloudflare, Inc. 1.9x 0.66 Cloudflare owns a scarce inline control point on the internet; if AI drives far more machine traffic, API calls, identity checks, and distributed code execution, it can sell more security, networking, and developer services on the same network, with the biggest upside coming from trust and governance layers rather than raw compute alone.
77 SITM ai communications hardware networking semiconductors SiTime Corporation 1.9x 0.60 SiTime is a scarce pure-play on rising timing content in AI racks, switches and XPUs; if it closes and integrates the Renesas timing assets, it can evolve from premium socket supplier to broader timing-stack vendor and roughly double equity value by May 2031 even with material multiple compression.
78 TSM ai hardware semiconductors Taiwan Semiconductor Manufacturing Company Limited 1.9x 0.92 TSMC should keep compounding because it owns the scarcest physical control points in AI—leading-edge wafer capacity and advanced packaging—but most upside will come from shipping more scarce capacity at better mix, not from a dramatic rerating.
79 NVDA ai hardware networking semiconductors software NVIDIA Corporation 1.9x 0.93 NVIDIA remains the default AI factory stack, so revenue can still more than double into 2031 through accelerators, systems, networking and software attach; but from a multi-trillion-dollar base, the stock likely compounds more like a dominant platform than a fresh scarcity trade.
80 ANET ai cloud hardware networking software Arista Networks, Inc. 1.8x 0.74 Arista is an AI-networking toll collector with unusually strong software-led workflow stickiness; if it converts today’s AI fabric demand into broader cloud, campus, WAN and control-layer attachment, revenue can nearly triple by 2031 while equity value compounds at a mid-teens rate even with multiple compression.
81 CRWD ai cloud cybersecurity enterprise software CrowdStrike Holdings, Inc. 1.8x 0.76 CrowdStrike should keep compounding as AI expands the attack surface and pushes enterprises toward fewer trusted control planes; its single-agent telemetry loop and cross-sell engine support strong revenue growth, but premium starting valuation and residual trust-repair work likely keep shareholder returns below business growth.
82 PL aerospace defense enterprise software space Planet Labs PBC 1.8x 0.62 Planet owns scarce daily Earth telemetry that becomes more valuable as AI makes interpretation cheap, so revenue can scale sharply through sovereign capacity, tasking, and embedded workflows; but with the stock already priced like strategic infrastructure, five-year equity upside depends on converting backlog into durable recurring economics, not on another major multiple expansion.
83 PLTR ai cloud defense enterprise software Palantir Technologies Inc. 1.8x 0.72 Palantir can keep compounding fast by becoming the governed action layer for AI inside defense and regulated enterprises, but because the stock already prices in rare durability and execution, strong business success is more likely to produce solid double-digit shareholder returns than another explosive rerating.
84 BKSY ai defense software space BlackSky Technology Inc. 1.8x 0.70 BlackSky can still roughly double equity value by 2031 if Gen-3 capacity, premium recurring contracts, and customer-funded sovereign deals turn it from a capital-heavy imagery vendor into a trusted defense data utility; from today’s valuation, most upside must come from execution, mix, and lower dilution rather than another big narrative rerating.
85 DELL ai cloud enterprise hardware networking Dell Technologies Inc. 1.7x 0.60 Dell is no longer just a PC and server assembler; enterprise AI lets it monetize speed-to-deploy, financing, support and full-stack bundling. If it converts backlog into profitable systems and recurring attach, it can compound like a better systems operator than a legacy hardware vendor, though not like a chip or software monopoly.
86 MPWR ai automotive energy hardware semiconductors Monolithic Power Systems, Inc. 1.7x 0.64 MPWR is a real AI-era power-density beneficiary: as servers, storage, autos, and robots need more efficient power conversion, MPS can grow revenue materially through higher content per system and module mix, but today’s premium valuation means most shareholder upside likely comes from execution and mix, not multiple expansion.
87 AAOI ai communications hardware networking semiconductors Applied Optoelectronics, Inc. 1.7x 0.67 AOI sits inside a real AI-bandwidth bottleneck: if it converts 800G and 1.6T qualifications into repeat hyperscale share and turns its Texas/Taiwan build-out into reliable output, revenue can scale several-fold by 2031; the stock outcome is more constrained because today’s valuation already discounts a lot of that success and optics still behaves like a product-margin market.
88 VRT ai energy hardware networking software Vertiv Holdings Co 1.7x 0.74 Vertiv is a scarce AI buildout supplier whose power, thermal, and service content rises with rack density; if it converts backlog cleanly, expands liquid-cooling capacity on time, and monetizes more lifecycle control and reservation economics, revenue can roughly triple by 2031, though stock upside should come more from execution than from another major rerating.
89 VST energy nuclear Vistra Corp. 1.7x 0.70 Vistra is a scarce-megawatt quality-upgrade story: AI-driven load growth, long-duration nuclear and gas contracts, Cogentrix, and disciplined buybacks can turn a cyclical power producer into a better compounding infrastructure platform over the next five years.
90 ETN aerospace automation energy hardware software Eaton Corporation plc 1.7x 0.72 Eaton is a high-quality AI-and-electrification picks-and-shovels compounder: it controls qualified power hardware, channel access and growing cooling content per site, so the likely win is sustained backlog conversion and richer system value capture, though the stock already prices in much of that advantage.
91 VICR ai defense energy hardware semiconductors Vicor Corporation 1.7x 0.62 Vicor controls a real AI-era bottleneck in dense power delivery, so revenue can scale sharply as advanced-product capacity and customer ramps expand; but because the stock already prices in much of that scarcity, shareholder returns likely lag the business growth unless licensing, subsystem bundling, and capacity-backed contracts broaden value capture.
92 MTSI communications defense hardware networking semiconductors MACOM Technology Solutions Holdings, Inc. 1.7x 0.65 MACOM owns real AI-era choke points in optical, copper and trusted RF semiconductors, so revenue can compound strongly as interconnect speeds rise; the catch is that today’s stock already prices in a lot of success, so shareholder upside depends on proving durable value capture above commodity component status.
93 STEM ai automation energy enterprise software Stem, Inc. 1.7x 0.60 Over five years, Stem can turn a distressed, hardware-tainted revenue base into a higher-quality energy operations software business; if PowerTrack becomes a trusted operating and compliance layer rather than just a monitoring tool, modest enterprise-value growth can still drive strong equity upside from today’s tiny market cap.
94 CEG energy nuclear Constellation Energy Corporation 1.6x 0.83 Constellation should compound as a scarce owner of clean-firm power, licensed nuclear sites, and interconnection-ready campuses that become more valuable as AI and electrification tighten U.S. power markets; the main limiter is not demand, but whether it converts scarcity into premium long-duration contracts faster than the stock already assumes.
95 MU ai cloud enterprise hardware semiconductors Micron Technology, Inc. 1.6x 0.80 Micron is one of the few public ways to own an AI hardware bottleneck: qualified HBM, DRAM and SSD supply. If it converts temporary scarcity into stickier supply-assurance economics while bringing new capacity online on time, revenue can remain structurally above prior cycle peaks through 2031; the upside is real, but equity gains are capped by capex intensity and cyclical pricing.
96 ON ai automotive energy hardware semiconductors ON Semiconductor Corporation 1.6x 0.70 A cyclical trough is masking a better power franchise: if onsemi converts qualified 900V EV sockets and AI rack-power wins into higher fab loading and mix, revenue can grow well, but shareholder returns are likely solid rather than explosive because much of the recovery is already reflected in the stock.
97 PWR cloud communications energy Quanta Services, Inc. 1.6x 0.60 Quanta is a scarce schedule-certainty layer for North America’s power buildout; AI-driven load growth expands its market, but shareholder returns from here depend on turning labor, trust and equipment access into better mix and durable premium economics, not just more backlog.
98 LITE ai communications hardware networking semiconductors Lumentum Holdings Inc. 1.6x 0.68 Lumentum owns a real AI-era bottleneck in qualified optical hardware, so revenue can still compound hard as AI clusters need more laser and switching content; the swing factor for shareholders is whether it converts today’s scarcity into durable contracts, broader customer breadth, and sustained margins before capacity normalizes.
99 EQIX ai cloud enterprise hardware networking Equinix, Inc. 1.6x 0.80 Equinix remains a premium AI-era toll booth: scarce powered metro capacity, neutral connectivity and dense ecosystem adjacency should drive durable revenue compounding, but shareholder upside is capped by physical delivery timelines, heavy capex and an already premium valuation.
100 RKLB aerospace defense hardware software space Rocket Lab Corporation 1.5x 0.70 Rocket Lab can compound into a broader space-and-defense prime as launch, spacecraft, and constrained subsystem content scale together, but from a 76710 market cap the stock now needs near-flawless Neutron execution and mix improvement for even moderate five-year returns.
101 HPE cloud enterprise hardware networking software Hewlett Packard Enterprise Company 1.5x 0.60 HPE can grow faster than its mature-hardware label if Juniper lifts networking mix, AI backlog converts into revenue, and GreenLake deepens from a hardware attachment into an operating and financing layer for private and sovereign AI; the upside is a higher-quality infrastructure compounder, not a software hypergrower.
102 NEE ai automation energy nuclear NextEra Energy, Inc. 1.5x 0.78 NextEra sits on scarce grid access, regulated recovery and a national development engine just as AI and electrification make reliable power the bottleneck; if FPL converts large-load interest and NEER turns backlog plus gas and transmission hubs into contracted assets, it can compound above utility peers, though the payoff is more likely premium utility growth than explosive rerating.